BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15755323)

  • 1. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Medicare coverage on use of invasive colorectal cancer screening tests.
    Ko CW; Kreuter W; Baldwin LM
    Arch Intern Med; 2002 Dec 9-23; 162(22):2581-6. PubMed ID: 12456230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of colorectal cancer screening participation in the United States.
    Ioannou GN; Chapko MK; Dominitz JA
    Am J Gastroenterol; 2003 Sep; 98(9):2082-91. PubMed ID: 14499792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries.
    O'Malley AS; Forrest CB; Feng S; Mandelblatt J
    Arch Intern Med; 2005 Oct; 165(18):2129-35. PubMed ID: 16217003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dually eligible and colorectal cancer screening: too little, too late?
    Carcaise-Edinboro P; Bradley CJ; Dahman B
    J Health Care Poor Underserved; 2009 Aug; 20(3):854-65. PubMed ID: 19648712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences for colorectal cancer screening.
    Leard LE; Savides TJ; Ganiats TG
    J Fam Pract; 1997 Sep; 45(3):211-8. PubMed ID: 9300000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in colorectal cancer test use in the medicare population, 1998-2005.
    Schenck AP; Peacock SC; Klabunde CN; Lapin P; Coan JF; Brown ML
    Am J Prev Med; 2009 Jul; 37(1):1-7. PubMed ID: 19423273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X; White MC; Peipins LA; Seeff LC
    J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underuse of colorectal cancer screening in a cohort of Medicare beneficiaries.
    Cooper GS; Doug Kou T
    Cancer; 2008 Jan; 112(2):293-9. PubMed ID: 18072273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal occult blood test use by Kansas medicare beneficiaries.
    Engelman KK; Ellerbeck EF; Ahluwalia JS; Nazir N; Velasco A
    Prev Med; 2001 Dec; 33(6):622-6. PubMed ID: 11716659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal carcinoma screening procedure use among primary care patients.
    Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
    Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey.
    Subramanian S; Amonkar MM; Hunt TL
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):409-16. PubMed ID: 15734966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.